Sarojini Budden

Rett Syndrome and Beyond: Recurrent Spontaneous and Familial MECP2 Mutations at CpG Hotspots

Mimi Wan, Stephen Sung Jae Lee, Xianyu Zhang et al. · The American Journal of Human Genetics · 1999 · 518 citations · Full text

Life Sciences, Genetics, Neuroscience +9

Is angelman syndrome an alternate result of del(15)(qllql3)?

R. Ellen Magenis, Michael G. Brown, Deborah A. Lacy et al. · American Journal of Medical Genetics · 1987 · 241 citations

Life Sciences, Genetics, Pediatrics +9

Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment

Angela J. McArthur, Sarojini Budden · Developmental Medicine & Child Neurology · 1998 · 208 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Comparison of the 15q deletions in Prader‐Willi and Angelman syndromes: Specific regions, extent of deletions, parental origin, and clinical consequences

R.E. Magenis, S Toth-Fejel, Leland Allen et al. · American Journal of Medical Genetics · 1990 · 198 citations

Life Sciences, Genetics, Cytogenetics +14

<i>FXYD1</i> is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and <i>Mecp2</i>-null mice

Vivianne Deng, Valérie Matagne, Fatima Banine et al. · Human Molecular Genetics · 2007 · 148 citations · Full text

Life Sciences, Genetics, Neuroscience +17